Back

Lack of evidence for functional luteinising hormone chorionic gonadotropin receptors in non-pregnant human endometrial stromal cells

Mann, O. N.; Kong, C.-S.; Lucas, E. S.; Brosens, J. J.; Hanyaloglu, A. C.; Brighton, P. J.

2022-01-06 pharmacology and toxicology
10.1101/2022.01.05.474837 bioRxiv
Show abstract

The human luteinising hormone chorionic gonadotropin receptor (LHCGR) is a G-protein coupled receptor activated by both human chorionic gonadotropin (hCG) and luteinizing hormone (LH), two structurally related gonadotropins with essential roles in ovulation and maintenance of the corpus luteum. LHCGR expression predominates in ovarian tissues where it elicits functional responses through cyclic adenosine mononucleotide (cAMP), Ca2+ and extracellular signal-regulated kinase (ERK) signalling. LHCGR has also been localized to the human endometrium, with purported roles in decidualization and implantation. However, these observations are contentious. In this investigation, transcripts encoding LHCGR were undetectable in bulk RNA sequencing datasets from whole cycling endometrial tissue and cultured human endometrial stromal cells (EnSC). However, analysis of single-cell RNA sequencing data revealed cell-to-cell transcriptional heterogeneity and identified a small subpopulation of stromal cells with discernible LHCGR transcripts. In HEK-293 cells expressing recombinant LHCGR, both hCG and LH elicited robust cAMP, Ca2+ and ERK signals that were absent in wild type HEK-293 cells. However, none of these responses were recapitulated in primary EnSC cultures. In addition, proliferation, viability and decidual transformation of EnSC were refractory to both hCG and LH, irrespective of treatment to induce differentiation. Although we challenge the assertion that LHCGR is expressed at a functionally active level in the human endometrium, the discovery of a discrete subpopulation of EnSC that express LHCGR transcripts may plausibly account for the conflicting evidence in the literature.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Molecular Human Reproduction
11 papers in training set
Top 0.1%
12.6%
2
Journal of Biological Chemistry
641 papers in training set
Top 0.1%
12.2%
3
Scientific Reports
3102 papers in training set
Top 8%
9.1%
4
Endocrinology
38 papers in training set
Top 0.1%
6.3%
5
JCI Insight
241 papers in training set
Top 0.5%
6.3%
6
eLife
5422 papers in training set
Top 14%
6.3%
50% of probability mass above
7
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 20%
3.6%
8
Biology of Reproduction
28 papers in training set
Top 0.1%
3.6%
9
The FASEB Journal
175 papers in training set
Top 0.3%
3.6%
10
PLOS ONE
4510 papers in training set
Top 42%
3.2%
11
Development
440 papers in training set
Top 1%
1.9%
12
Molecular Biology of the Cell
272 papers in training set
Top 1%
1.7%
13
PLOS Biology
408 papers in training set
Top 10%
1.6%
14
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.4%
1.6%
15
Frontiers in Endocrinology
53 papers in training set
Top 1%
1.3%
16
Frontiers in Immunology
586 papers in training set
Top 5%
1.3%
17
iScience
1063 papers in training set
Top 23%
1.1%
18
Science Translational Medicine
111 papers in training set
Top 4%
0.9%
19
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.9%
20
PLOS Genetics
756 papers in training set
Top 13%
0.9%
21
Journal of Virology
456 papers in training set
Top 3%
0.8%
22
Nature Communications
4913 papers in training set
Top 61%
0.8%
23
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
24
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 9%
0.7%
25
Science Advances
1098 papers in training set
Top 30%
0.7%
26
Stem Cell Reports
118 papers in training set
Top 1%
0.7%
27
Reproduction
11 papers in training set
Top 0.2%
0.6%
28
Frontiers in Genetics
197 papers in training set
Top 11%
0.6%
29
Life Science Alliance
263 papers in training set
Top 2%
0.6%